We are live on ! Find out more
Assenagon Asset Management

Assenagon Asset Management Portfolio holdings

AUM $80.2B
1-Year Est. Return 50.57%
This Fund
S&P 500
This Quarter Est. Return
+9.62%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
AUM
$29.5B
AUM Growth
+$4.81B
Cap. Flow
+$2.82B
Cap. Flow %
9.58%
Top 10 Hldgs %
32.79%
Holding
1,495
New
316
Increased
416
Reduced
406
Closed
318

Sector Composition

Rank Sector Weight
1 Technology 22.78%
2 Consumer Discretionary 14.1%
3 Communication Services 12.23%
4 Healthcare 10.23%
5 Financials 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APEN
701
DELISTED
Apollo Endosurgery, Inc.
APEN
$1.85M 0.01%
+227,975
New +$1.56M
VRTV
702
DELISTED
VERITIV CORPORATION
VRTV
$1.84M 0.01%
30,046
-64,181
-68% -$3.35M
INTU icon
703
Intuit
INTU
$89B
$1.84M 0.01%
3,761
+167
+5% +$72.4K
XYL icon
704
Xylem
XYL
$28.1B
$1.84M 0.01%
15,360
+2,197
+17% +$251K
NFE icon
705
New Fortress Energy
NFE
$101M
$1.84M 0.01%
+48,510
New +$2.07M
KO icon
706
Coca-Cola
KO
$375B
$1.84M 0.01%
33,923
-684,556
-95% -$37.2M
AGTC
707
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.83M 0.01%
468,803
-131,750
-22% -$546K
CAL icon
708
Caleres
CAL
$487M
$1.83M 0.01%
+66,941
New +$1.68M
DGX icon
709
Quest Diagnostics
DGX
$26.3B
$1.82M 0.01%
13,804
+605
+5% +$79.2K
BNY
710
Bank of New York Mellon
BNY
$107B
$1.81M 0.01%
35,318
+360
+1% +$18K
ZUMZ icon
711
Zumiez
ZUMZ
$339M
$1.81M 0.01%
+36,878
New +$1.66M
HHH icon
712
Howard Hughes
HHH
$4.03B
$1.8M 0.01%
19,421
+2,635
+16% +$261K
ARDX icon
713
Ardelyx
ARDX
$997M
$1.8M 0.01%
237,237
-435,668
-65% -$3.22M
DGII icon
714
Digi International
DGII
$3.1B
$1.8M 0.01%
89,351
+69,894
+359% +$1.31M
KMPR icon
715
Kemper
KMPR
$1.68B
$1.79M 0.01%
24,259
-38,118
-61% -$2.94M
SUM
716
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.79M 0.01%
52,329
+21,715
+71% +$685K
ALRM icon
717
Alarm.com
ALRM
$2.85B
$1.79M 0.01%
+21,122
New +$1.8M
R icon
718
Ryder
R
$10.1B
$1.79M 0.01%
24,063
-48,526
-67% -$3.84M
A icon
719
Agilent Technologies
A
$41.2B
$1.78M 0.01%
12,018
+1,150
+11% +$157K
ED icon
720
Consolidated Edison
ED
$39.9B
$1.76M 0.01%
24,611
-6,397
-21% -$491K
CSOD
721
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$1.76M 0.01%
+34,186
New +$1.58M
SEDG icon
722
SolarEdge
SEDG
$1.95B
$1.76M 0.01%
6,355
-3,092
-33% -$779K
CSLT
723
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.75M 0.01%
667,068
+263,112
+65% +$490K
VVX icon
724
V2X
VVX
$2.65B
$1.75M 0.01%
36,791
-37,660
-51% -$1.94M
WPM icon
725
Wheaton Precious Metals
WPM
$60.9B
$1.75M 0.01%
39,734
-147,847
-79% -$6.58M

Similar funds

Assenagon Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Assenagon Asset Management held 1,495 positions worth $29.5B, up 20% from $24.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Assenagon Asset Management deployed $2.82B of net new capital in Q2 2021, opening 316 new positions and adding to 416 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 1,426,193 shares worth $262M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Walt Disney, an estimated $361M trimmed.

  • Assenagon Asset Management's largest Q2 2021 buy was Alexion Pharmaceuticals: 1,426,193 shares worth $262M.
  • Assenagon Asset Management added most to Amazon in Q2 2021, an estimated $596M increase.
  • Assenagon Asset Management's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $361M.
  • Assenagon Asset Management fully exited INPHI CORPORATION in Q2 2021, selling an estimated $47.9M.
  • Assenagon Asset Management's ten largest holdings make up 33% of its $29.5B portfolio in Q2 2021.
  • Assenagon Asset Management opened 316 new positions and closed 318 in Q2 2021.
  • Assenagon Asset Management's portfolio value rose 20% quarter-over-quarter to $29.5B.

Based on Assenagon Asset Management's 13F filing for Q2 2021, filed 15 Jul 2021.